It’s been revealed that US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster.
Now, it includes children as young as 12, at least five months after they finish the primary vaccine series.
On Monday, the FDA expanded the emergency use authorization for Pfizer’s Covid-19 vaccine boosters to children ages 12 to 15.
CNN notes that the CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13-1 earlier Wednesday in favor of recommending the expanded use of Covid-19 boosters for children in this age group.
It’s also important to note the fact that CDC had authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in ages 16 and 17 in December.
“It is critical that we protect our children and teens from covid infection and the complications of severe disease,” CDC Director Dr. Rochelle Walensky said in a news release.
Walensky continued and said:
“Today, I endorsed ACIP’s vote to expand eligibility and strengthen our recommendations for booster doses. We now recommend that all adolescents aged 12-17 years should receive a booster shot 5 months after their primary series. This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations.”
Covid in the news
The latest reports reveal that Novak Djokovic’s chance to play for a 10th Australian Open title is now hanging into limbo. ESPN.com notes that the country denied him entry and canceled his visa because he failed to meet the requirements for an exemption to covid vaccination rules.
He announced on social media Tuesday that he had “exemption permission” and landed in Australia late Wednesday after receiving a medical exemption from the Victoria state government that was expected to shield him from the strict vaccination regulations in place for this year’s first major tennis tournament.
Check out the complete story in our previous article.